178 related articles for article (PubMed ID: 10891769)
1. [Iron and chronic liver disease (excluding genetic hemochromatosis and metabolic liver siderosis)].
Hezode C; Dhumeaux D
Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B82-7. PubMed ID: 10891769
[No Abstract] [Full Text] [Related]
2. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population.
Jaskiewicz K; Banach L; Lancaster E
Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800
[TBL] [Abstract][Full Text] [Related]
3. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.
Fargion S; Valenti L; Fracanzani AL
Dig Liver Dis; 2011 Feb; 43(2):89-95. PubMed ID: 20739232
[TBL] [Abstract][Full Text] [Related]
4. [Iron storage disease].
Horváth G; Dávid K
Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
[TBL] [Abstract][Full Text] [Related]
6. [From iron accumulation to organ damage].
Zaccone V; Gasbarrini G
Minerva Med; 2012 Apr; 103(2):123-40. PubMed ID: 22513517
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics.
Ventura P; Rosa MC; Abbati G; Marchini S; Grandone E; Vergura P; Tremosini S; Zeneroli ML
Liver Int; 2005 Feb; 25(1):49-56. PubMed ID: 15698398
[TBL] [Abstract][Full Text] [Related]
8. Hepatic iron overload and hepatocellular carcinoma.
Kew MC
Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
[TBL] [Abstract][Full Text] [Related]
9. [Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis].
Dhumeaux D; Hezode C
Bull Acad Natl Med; 2000; 184(2):349-54. PubMed ID: 10989543
[TBL] [Abstract][Full Text] [Related]
10. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
[TBL] [Abstract][Full Text] [Related]
11. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle.
Petrak J; Myslivcova D; Man P; Cmejla R; Cmejlova J; Vyoral D; Elleder M; Vulpe CD
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1490-8. PubMed ID: 17307722
[TBL] [Abstract][Full Text] [Related]
13. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
[TBL] [Abstract][Full Text] [Related]
14. Dietary iron overload in the African and hepatocellular carcinoma.
Kew MC; Asare GA
Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
[TBL] [Abstract][Full Text] [Related]
15. The global impact of hepatic fibrosis and end-stage liver disease.
Lim YS; Kim WR
Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
[TBL] [Abstract][Full Text] [Related]
17. [Syndrome of iron overload and its impact on the clinical course and risk of complications in patients with liver cirrhosis].
Mel'kina ES; Fedulenkova LA; Noskova KK; Petrakov AV; Varvanina GG; Drozdov VN
Eksp Klin Gastroenterol; 2011; (10):26-30. PubMed ID: 22629696
[TBL] [Abstract][Full Text] [Related]
18. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
[TBL] [Abstract][Full Text] [Related]
19. Screening for hepatocellular carcinoma: being old is not all bad.
Di Bisceglie AM
Am J Gastroenterol; 2004 Aug; 99(8):1477-8. PubMed ID: 15307863
[TBL] [Abstract][Full Text] [Related]
20. p53 mutation in hepatocellular carcinoma and chronic liver disease.
Ceyhan K; Akpolat I; Bozdoğan N; Kobat I; Ekinci C
Am J Gastroenterol; 1996 Jul; 91(7):1476-7. PubMed ID: 8678035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
